Oliver Gerhard Ottmann (Oliver G Ottmann, Oliver Ottmann)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

Blood

British journal of haematology

Leukemia & lymphoma

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Claudia Chiriches, Dilawar Khan, Maria Wieske, Nathalie Guillen, Michal Rokicki, Carol Guy, Marieangela Wilson, Kate J Heesom, Oliver Gerhard Ottmann, Martin Ruthardt
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia. Annals of hematology 101 (10) (2022)
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas A Schäfer, Oliver Gerhard Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Recher, Rebeca Rodriguez-Veiga, David Taussig, Norbert Vey, Sung Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H Wei
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood advances 6 (14) (2022)
Claudia Chiriches, Nathalie Guillen, Maria Wieske, Heba Elhaddad, Ecmel Mehmetbeyoglu, Caroline L Alvares, Dörte Becher, Paul Hole, Oliver Gerhard Ottmann, Martin Ruthardt
Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLoS genetics 18 (10) (2022)
Oliver Gerhard Ottmann, Frank Stegelmann, Massimo Breccia, Juan Luis Steegmann, Eduardo Olavarria, Paola Aimone, Jeffrey H Lipton
Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study. Leukemia & lymphoma 62 (3) (2020)
Hartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver Gerhard Ottmann
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. British journal of haematology 185 (3) (2018)
Oliver Gerhard Ottmann, Carsten Müller-Tidow, Alwin Krämer, Richard F Schlenk, Michael Lübbert, Gesine Bug, Utz Krug, Tilmann Bochtler, Florian Voss, Tillmann Taube, Dan Liu, Pilar Garin-Chesa, Hartmut Döhner
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British journal of haematology 184 (6) (2018)
Heike Pfeifer, Katharina Raum, Sandra Markovic, Verena Nowak, Stephanie Fey, Julia Obländer, Jovita Pressler, Verena Böhm, Monika Brüggemann, Lydia Wunderle, Andreas Hüttmann, Ralph Wäsch, Joachim Beck, Matthias Stelljes, Andreas Viardot, Fabian Lang, Dieter Hoelzer, Wolf-Karsten Hofmann, Hubert Serve, Christel Weiss, Nicola Goekbuget, Oliver Gerhard Ottmann, Daniel Nowak
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation. Blood 131 (13) (2018)
Inga Nagel, Marius Bartels, Johannes Duell, Hans-Heinrich Oberg, Sandra Ussat, Henrike Bruckmueller, Oliver Gerhard Ottmann, Heike Pfeifer, Heiko Trautmann, Nicola Gökbuget, Almuth Caliebe, Dieter Kabelitz, Michael Kneba, Heinz-August Horst, Dieter Hoelzer, Max S Topp, Ingolf Cascorbi, Reiner Siebert, Monika Brüggemann
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy. Blood 130 (18) (2017)
Mateusz Legut, Garry Dolton, Afsar Ali Mian, Oliver Gerhard Ottmann, Andrew K Sewell
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells. Blood 131 (3) (2017)
Philippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, Carlo Gambacorti Passerini, Sandrine Hayette, Jean-Michel Cayuela, Françoise Huguet, Thibaut Leguay, Patrice Chevallier, Celia Salanoubat, Caroline Bonmati, Magda Alexis, Mathilde Hunault, Sylvie Glaisner, Philippe Agape, Christian Berthou, Eric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumedaly Reman, Bruno Lioure, Xavier Thomas, Norbert Ifrah, Marina Lafage-Pochitaloff, Anne Bornand, Laure Morisset, Valérie Robin, Heike Pfeifer, Andre Delannoy, Josep Ribera, Renato Bassan, Marc Delord, Dieter Hoelzer, Herve Dombret, Oliver Gerhard Ottmann, null null
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL. Blood 128 (6) (2016)

Oliver Gerhard Ottmann.css-eqlu8i{font-size:small;padding-left:4px;} (Oliver G Ottmann, Oliver Ottmann)

Publication Activity (10 Years)

Top Topics

Top Venues

Oliver Gerhard Ottmann (Oliver G Ottmann, Oliver Ottmann)